BRD2 and Alzheimer disease: Prompted by these data, we asked the question: does FSH contribute to AD––and, if so, do the sharp, up to 10–fold increases in serum FSH across and beyond the menopausal transition account for the disproportionately high incidence of AD in aging women versus men, who display only a 3.5% annual rise in serum FSH28?